A Post Marketing Surveillance Study of INVOSSA K Inj.

NCT03412864 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2019-05-28

No results posted yet for this study

Summary

This study is post-marketing surveillance of Invossa K injection in patients with osteoarthritis.

Conditions

Sponsors & Collaborators

  • Kolon Life Science

    lead INDUSTRY

Principal Investigators

  • Oog Jin Shon, MD, PhD. · Yeungnam University Hospital

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-12
Primary Completion
2023-07-11
Completion
2023-07-11

Countries

  • South Korea

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03412864 on ClinicalTrials.gov